Q BioMed Inc. (QBIO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.94 Million | -4.3 Million | -6.23 Million | -4.1 Million | -6.45 Million | -5.58 Million |
| Net Income | -2.05 Million | -8.24 Million | -13.49 Million | -10.27 Million | -9.27 Million | -14.54 Million |
| Depreciation & Amortization | 50 Thousand | 50 Thousand | 50 Thousand | 50 Thousand | - | - |
| Deferred income taxes | - | 345.06 Thousand | 374.57 Thousand | 799.38 Thousand | - | - |
| Stock-based compensation | 903.82 Thousand | 2.33 Million | 6.57 Million | 2.49 Million | 2.65 Million | 6399.59 |
| Change in working capital | 1.75 Million | 796.86 Thousand | 312.9 Thousand | 1.69 Million | -51.67 Thousand | 32.38 Thousand |
| Other non-cash items | 1.28 Million | 408 Thousand | -52.87 Thousand | 1.13 Million | 2.87 Million | 8.92 Million |
| Investing Cash Flow | -3.14 Million | - | - | - | -500 Thousand | - |
| Investments in PPE | -4.00 | - | - | - | -500 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -3.14 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -3143.20 | - | - | - | -500.00 | - |
| Financing Cash Flow | 907.76 Thousand | 4.46 Million | 6.23 Million | 1.59 Million | 8.81 Million | 4.94 Million |
| Debt repayment | -652.73 Thousand | -3.45 Million | -1.96 Million | -970 Thousand | -3.86 Million | -2.5 Million |
| Dividends payments | - | -500.72 Thousand | -375.07 Thousand | - | - | - |
| Common Stock Repurchased | - | - | -1.96 Million | - | - | 487.5 Thousand |
| Common Stock Issuance | 120.03 Thousand | 1.01 Million | 322.95 Thousand | 623.25 Thousand | 4.94 Million | 2.37 Million |
| Other Financing Activities | 907.76 Thousand | 4.46 Million | 10.22 Million | 1.94 Million | 3.86 Million | 2.08 Million |
| Accounts receivables | 68.56 Thousand | -80.09 Thousand | -89.67 Thousand | - | - | - |
| Accounts payables | 1.47 Million | 838.69 Thousand | 569.19 Thousand | 1.4 Million | -71.3 Thousand | -34.39 Thousand |
| Inventory | - | -80.09 Thousand | -324 Thousand | - | - | - |
| Other working capital | -1.54 Million | 118.36 Thousand | 157.39 Thousand | 291.12 Thousand | 19.63 Thousand | 66.78 Thousand |
| Cash at beginning of period | 344 Thousand | 177.14 Thousand | 172.63 Thousand | 2.68 Million | 824.78 Thousand | 1.46 Million |
| Cash at end of period | 49.97 Thousand | 344 Thousand | 177.14 Thousand | 172.63 Thousand | 2.68 Million | 824.78 Thousand |
| Capital Expenditure | -4.00 | - | - | - | -500 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -294.03 Thousand | 166.86 Thousand | 4509.00 | -2.51 Million | 1.85 Million | -643.94 Thousand |
| Free Cash Flow | 1.94 Million | -4.3 Million | -6.23 Million | -4.1 Million | -6.95 Million | -5.58 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | -721.61 Thousand | -2.05 Million | 2.3 Million | -795.11 Thousand |
| Depreciation & Amortization | - | - | 12.5 Thousand | 50 Thousand | 12.5 Thousand | 12.5 Thousand |
| Deferred income taxes | - | - | -308.24 Thousand | - | - | - |
| Stock-based compensation | - | - | 16.03 Thousand | 903.82 Thousand | 64.29 Thousand | 158.59 Thousand |
| Change in working capital | - | - | 359.11 Thousand | 1.75 Million | 287.63 Thousand | 432.75 Thousand |
| Other non-cash items | - | - | 504.01 Thousand | 1.28 Million | 716.00 | -48.07 Thousand |
| Investing Cash Flow | - | - | - | -3.14 Million | -3.14 Million | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -3.14 Million | -3.14 Million | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -3143.20 | -3143.20 | - |
| Financing Cash Flow | - | - | 111.38 Thousand | 907.76 Thousand | 387.73 Thousand | 350 Thousand |
| Debt repayment | - | - | -111.38 Thousand | -652.73 Thousand | -302.73 Thousand | -350 Thousand |
| Dividends payments | - | - | -104.8 Thousand | -968.16 Thousand | -460.23 Thousand | - |
| Common Stock Repurchased | - | - | -111.38 Thousand | - | - | - |
| Common Stock Issuance | - | - | 381.95 Thousand | 120.03 Thousand | -99.92 Thousand | - |
| Other Financing Activities | - | - | 57.01 Thousand | 907.76 Thousand | 387.73 Thousand | 350 Thousand |
| Accounts receivables | - | - | 11.53 Thousand | 68.56 Thousand | 1.00 | 62.77 Thousand |
| Accounts payables | - | - | 296.7 Thousand | 1.47 Million | 210.08 Thousand | 320.47 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | -308.24 Thousand | -1.54 Million | 77.54 Thousand | 49.5 Thousand |
| Cash at beginning of period | - | 23.17 Thousand | 344 Thousand | 344 Thousand | 137.82 Thousand | 27.16 Thousand |
| Cash at end of period | - | 23.17 Thousand | 49.97 Thousand | 49.97 Thousand | 49.97 Thousand | 137.82 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -294.03 Thousand | -294.03 Thousand | -87.85 Thousand | 110.66 Thousand |
| Free Cash Flow | - | - | -138.18 Thousand | 1.94 Million | 2.66 Million | -239.34 Thousand |
TNXT
CPI
INEP3
603726
3465
ADWPF